Is treatment with liraglutide efficient?
Mezquita Raya, Pedro; Reyes García, Rebeca.
; 61(4): 202-8, 2014 Apr.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-24071060
Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China.
Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece.
Cost effectiveness of liraglutide in type II diabetes: a systematic review.
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus.
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
Clinical use of GLP-1 agonists and DPP4 inhibitors.
Liraglutide: a review of its use in the management of type 2 diabetes mellitus.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity.
HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.